<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the study was to evaluate risk factors of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and extra-cerebral target organ damage in patients with <z:hpo ids='HP_0000822'>hypertension</z:hpo> and vascular based mild <z:e sem="disease" ids="C0025261" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A group of the study included 20 persons at age of 54-75 (8 males and 12 females) with mild vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (20-25 pts in MMSE, 22.8 +/- 1.73) with treated mild <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A diagnosis of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> was confirmed in MRI by two independent experts </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> examined patients presented multiinfarction changes in central <z:mp ids='MP_0008912'>nervous</z:mp> system as a cause of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The study protocol contained present history, physical examination, 24-hour ambulatory blood pressure monitoring (ABPM), ECG, biochemical tests: total cholesterol, <z:chebi fb="17" ids="39025">HDL</z:chebi>-Ch, <z:chebi fb="15" ids="39026">LDL</z:chebi>-Ch, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="20" ids="16199">urea</z:chebi>, <z:chebi fb="0" ids="16737">creatinine</z:chebi> plasma levels and urine test for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In part of the study group (55%) echocardiography with posterior wall (PW) thickness and ejection fraction (EF) evaluation was performed </plain></SENT>
<SENT sid="6" pm="."><plain>In the analysed group mean 24-hour blood pressure values were not elevated (SBP 130.8 +/- 15.8 mm Hg and <z:chebi fb="4" ids="35861">DBP</z:chebi> 77.6 +/- 9.2 mm Hg at day, respectively 121.6 +/- 17.1 mm Hg and 68.2 +/- 11.6 mm Hg at night) </plain></SENT>
<SENT sid="7" pm="."><plain>No significant (&gt; 10%) nocturnal SBP decrease was observed, however <z:chebi fb="4" ids="35861">DBP</z:chebi> fall was noticed </plain></SENT>
<SENT sid="8" pm="."><plain>Either total cholesterol (n &lt; 5.2 mmol/l) or <z:chebi fb="15" ids="39026">LDL</z:chebi>-Ch (n &lt; 3.5 mmol/l) plasma levels were increased in patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and ranged respectively 5.8 +/- 0.9 and 3.7 +/- 0.9 mmol/l, <z:chebi fb="17" ids="39025">HDL</z:chebi>-Ch and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> levels remained <z:mpath ids='MPATH_458'>normal</z:mpath> (respectively 1.7 +/- 0.5 and 1.5 +/- 1.1 mmol/l) </plain></SENT>
<SENT sid="9" pm="."><plain>Mean <z:chebi fb="20" ids="16199">urea</z:chebi> and <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels were maintained in <z:mpath ids='MPATH_458'>normal</z:mpath> range (<z:chebi fb="20" ids="16199">urea</z:chebi> 5.8 +/- 1.7 mmol/l, <z:chebi fb="0" ids="16737">creatinine</z:chebi> 75.5 +/- 15.1 mumol/l) </plain></SENT>
<SENT sid="10" pm="."><plain>In a part of study group (35%) <z:mp ids='MP_0002959'>microalbuminuria</z:mp> was presented (urine albumine &gt; 20 mg/l) </plain></SENT>
<SENT sid="11" pm="."><plain>In majority of patients with <z:hpo ids='HP_0000822'>hypertension</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> a few risk factors co-existed </plain></SENT>
<SENT sid="12" pm="."><plain>No systolic blood pressure decrease observed at night in 24-hour blood pressure monitoring, though <z:mpath ids='MPATH_458'>normal</z:mpath> mean values, can play an important role in <z:hpo ids='HP_0002597'>vascular abnormalities</z:hpo> progression </plain></SENT>
</text></document>